Bank of America
PACB icon

Bank of America’s Pacific Biosciences PACB Stock Holding History

Bank of America’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$303K – 7430
2019
Q2 		$303K Buy
+50,000
New +$351K ﹤0.01% 5404
2014
Q3 		– Sell
-4,900
Closed -$30K – 8125
2014
Q2 		$30K Buy
+4,900
New +$24.5K ﹤0.01% 6976

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America's PACB Position: Q1 2026 in Review

Bank of America reduced its Pacific Biosciences (PACB) stake by 10% in Q1 2026, selling an estimated $337K and leaving 1,666,706 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #4060.

Bank of America first reported a position in PACB in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.78M in Q2 2021. 230 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Bank of America held 1,666,706 shares of Pacific Biosciences worth $2.2M as of Q1 2026.
  • Bank of America sold 188,108 Pacific Biosciences shares in Q1 2026, an estimated $337K.
  • Pacific Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4060 holding.
  • Bank of America first reported a position in Pacific Biosciences in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Pacific Biosciences position peaked at $9.78M in Q2 2021.
  • 230 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.